• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫浆液性乳头状癌

Uterine papillary serous carcinoma.

作者信息

Moore Kathleen N, Fader Amanda Nickles

机构信息

Department of Gynecologic Oncology, University of Oklahoma, Oklahoma City, Oklahoma, USA.

出版信息

Clin Obstet Gynecol. 2011 Jun;54(2):278-91. doi: 10.1097/GRF.0b013e318218c755.

DOI:10.1097/GRF.0b013e318218c755
PMID:21508697
Abstract

Uterine papillary serous carcinoma (UPSC) is a histologic variant of endometrial cancer that accounts for only 10% of new cases of uterine cancer but is responsible for 40% of deaths from the disease. UPSC is an aggressive tumor with a predilection for early spread beyond the uterus. Treatment for UPSC typically entails surgery and in most women is followed by multimodality adjuvant therapy. In this review, we describe the epidemiology, natural history, treatment, and outcome of UPSC.

摘要

子宫浆液性乳头状癌(UPSC)是子宫内膜癌的一种组织学亚型,仅占子宫癌新发病例的10%,但却导致了该疾病40%的死亡。UPSC是一种侵袭性肿瘤,易早期扩散至子宫外。UPSC的治疗通常需要手术,大多数女性术后还需接受多模式辅助治疗。在本综述中,我们描述了UPSC的流行病学、自然病程、治疗及预后情况。

相似文献

1
Uterine papillary serous carcinoma.子宫浆液性乳头状癌
Clin Obstet Gynecol. 2011 Jun;54(2):278-91. doi: 10.1097/GRF.0b013e318218c755.
2
Optimal surgical debulking in uterine papillary serous carcinoma affects survival.子宫乳头状浆液性癌的最佳手术减瘤术影响生存。
Gynecol Oncol. 2011 Jun 1;121(3):581-5. doi: 10.1016/j.ygyno.2010.11.048. Epub 2011 Mar 25.
3
The management of serous papillary uterine cancer.浆液性乳头状子宫癌的管理
Curr Opin Oncol. 2006 Sep;18(5):494-9. doi: 10.1097/01.cco.0000239890.36408.75.
4
[Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma].33例子宫浆液性乳头状癌的临床与病理分析
Zhonghua Fu Chan Ke Za Zhi. 2006 Dec;41(12):817-21.
5
Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.局限于或累及子宫内膜息肉的早期乳头状浆液性或透明细胞癌:辅助治疗与无辅助治疗的结局。
Gynecol Oncol. 2013 Dec;131(3):598-603. doi: 10.1016/j.ygyno.2013.10.010. Epub 2013 Oct 14.
6
Adjuvant therapy for patients with stage I papillary serous endometrial cancer.I期乳头状浆液性子宫内膜癌患者的辅助治疗。
Eur J Surg Oncol. 2006 Apr;32(3):358-62. doi: 10.1016/j.ejso.2005.12.001. Epub 2006 Jan 18.
7
Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.1984年至1994年间,汤姆·贝克癌症中心对侵袭性子宫内膜癌组织学变异型的管理。
Gynecol Oncol. 2000 May;77(2):248-53. doi: 10.1006/gyno.2000.5746.
8
Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management.浆液性子宫内膜上皮内癌作为子宫乳头状浆液性癌的早期形式:其发病机制认识的最新进展及关于病理和临床管理的当前观点
Gynecol Oncol. 2005 Mar;96(3):579-82. doi: 10.1016/j.ygyno.2004.12.045.
9
Uterine papillary serous cancer: a review of the literature.子宫乳头状浆液性癌:文献回顾。
Gynecol Oncol. 2012 Dec;127(3):651-61. doi: 10.1016/j.ygyno.2012.09.012. Epub 2012 Sep 20.
10
Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006.1992年至2006年罗斯韦尔帕克癌症研究所对早期子宫浆液性乳头状癌的治疗
Gynecol Oncol. 2009 Nov;115(2):249-56. doi: 10.1016/j.ygyno.2009.07.004. Epub 2009 Aug 18.

引用本文的文献

1
Narrative review on the evolving role of HER2/neu targeting in uterine serous cancers.关于HER2/neu靶向治疗在子宫浆液性癌中不断演变作用的叙述性综述。
Ann Transl Med. 2024 Aug 1;12(4):69. doi: 10.21037/atm-23-1465. Epub 2023 Nov 9.
2
Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study.高级别浆液性子宫内膜腺癌淋巴管血管间隙侵犯(LVSI)肿瘤及肿瘤微环境细胞图谱:病例研究。
Int J Mol Sci. 2024 Mar 19;25(6):3441. doi: 10.3390/ijms25063441.
3
Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling.
通过多区域微量采样绘制子宫浆液性癌的三维肿瘤内蛋白质组异质性图谱。
Clin Proteomics. 2024 Jan 22;21(1):4. doi: 10.1186/s12014-024-09451-2.
4
Comparison of clinical characteristics and prognosis between type I and type II endometrial cancer: a single-center retrospective study.I型与II型子宫内膜癌的临床特征及预后比较:一项单中心回顾性研究。
Discov Oncol. 2023 Nov 23;14(1):211. doi: 10.1007/s12672-023-00820-1.
5
A review of basic to clinical targeted therapy and immunotherapy in uterine serous cancer.子宫浆液性癌的基础至临床靶向治疗和免疫治疗的综述。
Mol Biol Rep. 2023 Aug;50(8):6901-6912. doi: 10.1007/s11033-023-08580-5. Epub 2023 Jun 16.
6
Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation?子宫内膜癌的治疗与分子诊断升级——为子宫内膜保护带来新工具?
Int J Mol Sci. 2023 Jun 5;24(11):9780. doi: 10.3390/ijms24119780.
7
The clinico pathological features and survival in serous endometrial cancers.浆液性子宫内膜癌的临床病理特征与生存情况
Gynecol Oncol Rep. 2023 Apr 28;47:101194. doi: 10.1016/j.gore.2023.101194. eCollection 2023 Jun.
8
Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide.使用变异解读和临床决策支持软件MH Guide确定癌症基因组图谱(TCGA)子宫内膜癌分子亚型
Cancers (Basel). 2023 Mar 30;15(7):2053. doi: 10.3390/cancers15072053.
9
Hereditary Women's Cancer: Management and Risk-Reducing Surgery.遗传性女性癌症:管理与降低风险手术。
Medicina (Kaunas). 2023 Feb 6;59(2):300. doi: 10.3390/medicina59020300.
10
Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations.对一名非肌层浸润性子宫浆液性癌局限于息肉且腹膜冲洗液中存在体细胞ARHGAP35和KRAS突变的患者的评估。
Cureus. 2022 Jul 8;14(7):e26663. doi: 10.7759/cureus.26663. eCollection 2022 Jul.